title: Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.
authors.affiliation: Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.
authors.forename: Sonia
authors.initials: S
authors.lastname: Rodríguez-Nóvoa
authors.forename: Pablo
authors.initials: P
authors.lastname: Labarga
authors.forename: Antonio
authors.initials: A
authors.lastname: D'avolio
authors.forename: Pablo
authors.initials: P
authors.lastname: Barreiro
authors.forename: Marta
authors.initials: M
authors.lastname: Albalate
authors.forename: Eugenia
authors.initials: E
authors.lastname: Vispo
authors.forename: Carmen
authors.initials: C
authors.lastname: Solera
authors.forename: Marco
authors.initials: M
authors.lastname: Siccardi
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonora
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Perri
authors.forename: Vincent
authors.initials: V
authors.lastname: Soriano
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007677:Kidney Function Tests; D007684:Kidney Tubules / Q000187:drug effects / Q000293:injuries; D063065:Organophosphonates / Q000009:adverse effects* / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000097:blood; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine